Cronos Group Inc. (CRON) vs Eton Pharmaceuticals, Inc. (ETON)
- Cronos Group Inc. CRON 3.22 +0.63%
- Eton Pharmaceuticals, Inc. ETON 50.40 −1.81%
Cronos Group Inc. and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. is the larger, with a market value of $1.5B against $1.2B — 1.2× the size. Cronos Group Inc. trades at the lower P/E: 16.1× against 107×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 81.5% against 37.5%. Cronos Group Inc. has the higher net margin (20.9% vs 12.0%) and the lower return on invested capital (−0.34% vs 21.4%). Across the 20 metrics below, Cronos Group Inc. leads on 11 and Eton Pharmaceuticals, Inc. on 9.
Valuation
Profitability
| Metric | CRON | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 45.86% | 57.87% | 53.94% |
| Operating margin | (0.96%) | 15.44% | 0.00% |
| Net margin | 20.91% | 12.02% | 0.00% |
| Free cash flow margin | 27.61% | (7.94%) | 0.00% |
| Return on equity | 3.33% | 35.97% | (0.40%) |
| Return on assets | 3.18% | 11.67% | (3.32%) |
| Return on invested capital | (0.34%) | 21.39% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack